Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Research

| More

Greenlam Industries - Exports continue to drive outperformance - ICICI Securities

Posted On: 2020-07-29 22:15:08


Greenlam Industries (GRLM) has reported a decent set of numbers led by better-than-expected recovery in its international business (laminate export revenue declining mere 12.9% YoY). However, domestic laminates revenue declined 65.7% YoY marred by Covid-19 led intermittent lockdown and muted real estate sector demand. Veneer and allied product segment continued to disappoint with losses swelling YoY due to operating deleverage. EBITDA margin came in at 4.9% (I-Sec: 5.3%), down 540bps YoY, due to operating deleverage. With GRLM foreseeing strong market share gain opportunity in both domestic and export laminate markets in near to medium term, we build-in a steady-state recovery in laminates segment starting Q2FY21. Maintain HOLD.

- Valuation and outlook: Factoring in largely in-line Q1FY21 outperformance, we maintain our revenue/PAT estimates for FY21E/FY22E. We expect the company to exhibit revenue and PAT CAGRs of 1.7% and 5%, respectively, over FY20-FY22E. We maintain HOLD with an unchanged target price of Rs792, valuing the stock at 20x FY22E earnings.

- Laminates and allied product segment - better-than-expected recovery in exports helps mitigate decline in domestic volumes: Overall laminate revenue in Q1FY21 was down 40.7% YoY - largely due to 54.5% decline in domestic volumes. Export revenue declined merely 12.9% YoY aided by 21.1% YoY volume decline and 12% YoY increase in realisations driven by the recent commissioning of large-sized laminate capacity at Nalagarh. Despite decline in domestic volume growth, segmental gross margin improved 20bps YoY aided by superior product mix and lower input costs. EBITDA margin declined 410bps YoY due to operating deleverage. We expect laminate and allied product segment to clock revenue and EBIDTA CAGRs of 2.2% and 3.5%, respectively, over FY20-FY22E.

- Veneer and allied product segment - revenue declined sharply by 66.5% YoY: Veneer and allied product revenue declined 66.5% YoY largely due to the discretionary nature of the product. Decorative veneer revenue declined 75% YoY, while revenues of EWF/ED segments shrunk 71%/27%, respectively. With volume disruption in niche segments (EWF and ED) likely to prevail in the near term, EBITDA breakeven in both these businesses would defer to FY22E. We expect veneer and allied product segment to register revenue and EBIDTA CAGRs of - 1.1% and 125%, respectively, over FY20-FY22E.

- Loss after tax at Rs77mn (I-Sec: Rs57mn): Consolidated loss after tax came in at Rs77mn due to muted performance of domestic laminate and veneer and allied product segments and higher than expected interest cost. We expect PAT to grow at 5% CAGR over FY20-FY22E.

Shares of Greenlam Industries Ltd was last trading in BSE at Rs.740 as compared to the previous close of Rs. 741.15. The total number of shares traded during the day was 1427 in over 383 trades.

The stock hit an intraday high of Rs. 769 and intraday low of 705.45. The net turnover during the day was Rs. 1060551.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com


Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

HeidelbergCement India - Play on better priced Central India; initiate with BUY - ICICI Securities

Healthcare - Diagnostics: Multiple tailwinds likely to emerge - ICICI Securities

Mazagon Dock Shipbuilders Ltd - IPO Review - ICICI Securities

Persistent Systems - 28th September 2020 - Angel Broking

Canara Bank - 28th September 2020 - Angel Broking

Subscribe to UTI Asset Management Company Limited - IPO Note - Angel Broking

Multiplex Sector - Mr. Jyoti Roy - DVP - Equity Strategist, Angel Broking Ltd

Sale of Sequent stake to Strides Pharma - Angel Broking

Subscribe to Mazagon Dock Shipbuilders Ltd - IPO Note - Angel Broking

JSW Energy - First big renewable step - ICICI Securities

V-MART Retail - Best play in value fashion segment; initiating with BUY - ICICI Securities

Gas sector - New winners and losers likely on policy changes in gas sector - ICICI Securities

Mazagon Dock Shipbuilders Limited - IPO Note - Geojit

UTI Asset Management Company Limited - IPO Note - Geojit

Preview on RBI Monetary Policy - Oct 2020 - Shanti Ekambaram

Rollover Report for September 2020 - October 2020: Angel Broking

Covid Recovery Pulse - Sep 25, 2020 - ICICI Securities

Quick Comment - Suven Pharmaceuticals - ICICI Securities

Derivatives Strategy - Sep 25, 2020 - Positional Option - ICICI Securities

Gladiator Stocks - Ramco Cement - ICICI Securities

IPO Review - UTI Asset Management Company - ICICI Securities

Stock of the Day - Zensar Technologies - Sep 25, 2020 - Angel Broking

Accenture Q4FY2020 Result - Angel Broking

Granules India receives ANDA approval - Angel Broking

Zydus Cadila receives US FDA approval - Angel Broking

Cipla - ANDA approval - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

Mindspace REIT - Mr. Yash Gupta - Equity Research Associate, Angel Broking Ltd

UTI AMC - IPO - Mr. Jaikishan Parmar - Sr. Equity Research Analyst, Angel Broking Ltd

Balkrishna Industries - Growth momentum continues - ICICI Securities

Rollover Analysis (September 25): Nifty starts October series with low OI amid high volatility

Derivatives View (September 25): Sell Bank Nifty in range of 20650-20750 - ICICI Securities

Rollover Analysis - Sept 20: Selling climax on expiry as markets crumble - YES Securities

Zydus Wellness - Leadership in niche categories; initiate at BUY - ICICI Securities

Power - Setting the stage - ICICI Securities

Company Update - Elgi Equipments - ICICI Securities

Nano Nivesh - The Anup Engineering - ICICI Securities

RBI OMO announcement of Rs. 10000 crore - Angel Broking

TCS deal win - Sep 24, 2020 - Angel Broking

View on Pre-Monetary Policy by Upasna Bhardwaj, Senior Economist at Kotak Mahindra Bank

US FDA approval to Zydus Cadila - Angel Broking

HDFC Securities Institutional Research Desk: Cement Sector Thematic - Spotting the sweet spot

Bharat Forge - Expectation hurdle remains steep - ICICI Securities

Auto

Mutual Fund Review - September, 2020 - ICICI Securities

UTI AMC announces IPO date - Angel Broking

Asian Paints - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Britannia Industries - Mr. Amarjeet Maurya - AVP - Mid Caps, Angel Broking Ltd

Hexaware Technologies (Not Rated): Hexaware accepts 475/share as final delisting price - ICICI Securities

CAMS IPO - Day 2 Subscription - Angel Boking

Chemcon Speciality Chemicals - IPO subscribed 12.62 times on second day - Angel Broking







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019